Aus coViki
Wechseln zu: Navigation, Suche

Plamapheresis, Immunoadsorption, IVIG, MARS, Cytosorb,

  • GET 2020. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19 Extract
  • GET 2020. A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19 Extract
  • GET ä. A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System Extract
  • GET 2020. [Clinical observation of 6 severe COVID-19 patients treated with plasma exchange or tocilizumab]. Extract
  • GET 2020. Application of plasma exchange in association with higher dose CVVH in Cytokine Storm Complicating COVID-19 Extract
  • GET 2020. Serum albumin-mediated strategy for the effective targeting of SARS-CoV-2 Extract
  • GET 2020. High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019 Extract
  • GET ä. SARS-CoV-2 infection complicated by inflammatory syndrome Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? Extract
  • GET ä. Plasmapheresis treatment in COVID-19?related autoimmune meningoencephalitis: Case series Extract
  • GET 2020. Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab. Extract
  • GET 2020. Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens. Extract
  • GET 2020. Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification. Extract
  • GET 2020. Editorial - High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patients. Extract
  • GET 2020. Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19. Extract
  • GET 2020. Successful intravenous immunoglobulin treatment in severe COVID-19 pneumonia. Extract
  • GET 2020. Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation. Extract
  • GET 2020. Positive Outcome in a COVID-19 patient with Common Variable Immunodeficiency after IVIG. Extract
  • GET 2020. Therapeutic Plasma Exchange in Adults with Severe COVID-19 Infection. Extract
  • GET 2020. The Application Of Plasmapheresis For Covid-19 Patients. Extract
  • GET 2020. Selective C-reactive protein (CRP) apheresis for Covid-19 patients suffering from organ damage. Extract
  • GET 2020. First do no harm-beware the risk of therapeutic plasma exchange in severe COVID-19. Extract
  • GET 2020. Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure. Extract
  • GET 2020. COVID-19 Pandemic Hemoperfusion Therapy Versus Plasma Exchange Therapy in Intensive Care. Extract
  • GET 2020. Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: A retrospective study. Extract
  • GET 2020. Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies. Extract
  • GET 2020. Therapeutic plasma exchange as a rescue therapy in patients with coronavirus disease 2019: a case series. Extract
  • GET 2020. The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure. Extract
  • GET 2020. Anti-SARS-CoV-2 hyperimmune plasma workflow. Extract
  • GET 2020. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities. Extract
  • GET 2020. Convalescent plasma: possible therapy for novel coronavirus disease 2019. Extract
Meine Werkzeuge